鶹ý

Wet AMD: Current Perspectives

MedpageToday
Condition Center Home > Peer-to-Peer Videos

Video: Cataract Surgery in Wet AMD: Does it Affect Visual Acuity?

—Sarju Patel, MD, MPH, MSc, discusses the conflicting evidence surrounding cataract surgery in wet AMD patients. His takehome: surgery will improve vision without increasing treatment burden in the short term, however long-term outcomes require further study. (2:37)

Published:

OCT Biomarkers in Wet AMD

Sections

More On This Topic

image
Ophthalmic Care in the US: Racial Disparities Are Prevalent
Researchers conducted a large observational study to provide “a snapshot of US ophthalmic care” that they hoped would provide information linking certain patient characteristics with eye care use and the prevalence of blindness.
image
OCT Biomarkers in Wet AMD
Lots of work is currently being done in the field of OCT imaging, explains Sarju Patel, MD, MPH, MSc. In this video, he discusses markers that are already established and widely used, as well as things to look forward to in the future.
image
Q&A with Zain S. Hussain: AMD Among Asian Medicare Beneficiaries
In an interview with 鶹ý, Hussain discusses the findings from his study analyzing the prevalence of AMD among Asian American populations.
image
In Wet AMD, Can AI Accurately Monitor Retinal Fluid?
A study evaluated the potential of automated deep learning by comparing the value of manually extracted data from high-resolution 3-dimensional optical coherence tomography imaging versus automated measurements in patients with neovascular age-related macular degeneration.
image
Suspending Advanced Neovascular AMD Treatment: Visual and Anatomic Outcomes
Utilizing data from the US, investigators found that suspension of anti-VEGF therapy in low-vision patients followed by regular monitoring may be a reasonable course.
image
Age-Related Macular Degeneration: Circulating Metabolites, Genetics, and Lifestyle
AMD is associated with altered levels of circulating metabolites, but it is unclear how these changes are associated with genetic and lifestyle risks.  These researchers identified novel metabolites that differ by stage of AMD.